Startup to serially turn skin cells into any other cells has been launched

GC Therapeutics has entered the market to develop a commercially available platform that allows for affordable programming of induced stem cells. The technology can be used to grow cells with defined, non-specific features and functions to target specific diseases. To begin with, the company plans to focus on cell therapy for gastrointestinal, neurological and immunological disorders.

Medicine

Biotech

Comments

Neuralink's Revolutionary Technology: A New Era of Vision for the Blind

Neuralink has created a technology that will allow people who have lost their eyes to see, as well as those who are blind from birth (but with a healthy visual cortex). In the first stages, such “vision” will have a low resolution, like Atari's 8-bit graphics, but gradually it will “surpass natural vision” and even allow people to see in infrared, ultraviolet or radar, Musk promises. The U.S. D

Medicine

Biotech

Pavel Ryzhikh

46 subscribers

16 days ago

FDA approved first self-administered flu vaccine

The U.S. Food and Drug Administration (FDA) has approved patients or their caregivers to self-administer the flu vaccine in the form of a nasal spray, according to a press release from the organization. The drug FluMist is approved for use to prevent influenza caused by A and B viruses in people ages 2 to 49. It was licensed for use in ages 5-49 in 2003, and 2-5 in 2007, but only when administered

Medicine

Pharma

Arch

Disclaimer Terms of Use

All trademarks, logos, and brands are the property of their respective owners. All company, product, and service names used in this website are for identification purposes only.

Startup to serially turn skin cells into any other cells has been launched

Recommended

Neuralink's Revolutionary Technology: A New Era of Vision for the Blind

FDA approved first self-administered flu vaccine